title: Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients.
authors.forename: M
authors.initials: M
authors.lastname: Pierantozzi
authors.forename: A
authors.initials: A
authors.lastname: Pietroiusti
authors.forename: A
authors.initials: A
authors.lastname: Galante
authors.forename: G
authors.initials: G
authors.lastname: Sancesario
authors.forename: G
authors.initials: G
authors.lastname: Lunardi
authors.forename: E
authors.initials: E
authors.lastname: Fedele
authors.forename: P
authors.initials: P
authors.lastname: Giacomini
authors.forename: P
authors.initials: P
authors.lastname: Stanzione
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000704:Analysis of Variance; D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D019540:Area Under Curve; D001682:Biological Availability; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D016481:Helicobacter Infections / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007980:Levodopa / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D009853:Omeprazole / Q000627:therapeutic use; D010300:Parkinson Disease / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D007980:Levodopa; D009853:Omeprazole